Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
642 hedge funds and large institutions have $25.6B invested in Allergan Inc in 2013 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 219 increasing their positions, 267 reducing their positions, and 67 closing their positions.
22% more funds holding in top 10
Funds holding in top 10: 9 → 11 (+2)
17% more capital invested
Capital invested by funds: $21.9B → $25.6B (+$3.63B)
0% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 67
1% less funds holding
Funds holding: 648 → 642 (-6)
16% less call options, than puts
Call options by funds: $180M | Put options by funds: $213M
18% less repeat investments, than reductions
Existing positions increased: 219 | Existing positions reduced: 267
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$240M |
| 2 |
O
OppenheimerFunds
New York
|
+$239M |
| 3 |
VAM
Visium Asset Management
New York
|
+$145M |
| 4 |
PC
PointState Capital
New York
|
+$91.7M |
| 5 |
SI
Scharf Investments
Los Gatos,
California
|
+$89.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$213M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$195M |
| 3 |
JP Morgan Chase
New York
|
-$153M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$103M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$87.4M |
AGN Hedge Fund Activity: Q3 2013 in Review
642 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2013, worth a combined $25.6B — up 17% from $21.9B a quarter earlier.
Fund positioning in AGN was balanced in Q3 2013: 67 funds opened new positions, 67 closed out, 219 added to existing stakes and 267 trimmed.
The largest buyer was Jennison Associates, adding an estimated $240M. The largest seller was Fidelity Investments, cutting an estimated $213M.
- 642 institutional investors held Allergan Inc (AGN) as of Q3 2013, down from 648 in Q2 2013.
- Funds reported $25.6B of Allergan Inc stock for Q3 2013, up 17% quarter-over-quarter.
- 67 funds opened new Allergan Inc positions in Q3 2013 and 67 closed out, a net change of 0 holders.
- The largest Allergan Inc buyer in Q3 2013 was Jennison Associates, an estimated $240M added.
- The largest Allergan Inc seller in Q3 2013 was Fidelity Investments, an estimated $213M sold.
Based on aggregated 13F filings for Q3 2013.